Boston Scientific (BSX) Assets Average (2009 - 2026)

Boston Scientific has disclosed Assets Average across 18 years of filings, most recently posting $44.8 billion for Q2 2026.

• In Q2 2026, Assets Average rose 9.63% year-over-year to $44.8 billion; the TTM figure through Jun 2026 stood at $44.8 billion (up 9.63% YoY), while the FY2025 annual figure was $41.5 billion, up 11.45% from the prior year.
• Assets Average came in at $44.8 billion for Q2 2026 at Boston Scientific, up from $44.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $44.8 billion in Q2 2026 to a low of $32.1 billion in Q3 2022.
• Average Assets Average over 5 years is $37.1 billion, with a median of $36.4 billion recorded in 2024.
• Year-over-year, Assets Average increased 0.48% in 2022 and gained 12.08% in 2025.
• Over 5 years, Assets Average stood at $32.2 billion in 2022, then rose by 7.39% to $34.6 billion in 2023, then gained by 11.99% to $38.7 billion in 2024, then climbed by 11.5% to $43.2 billion in 2025, then rose by 3.69% to $44.8 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $44.8 billion in Q2 2026, $44.0 billion in Q1 2026, and $43.2 billion in Q4 2025.